PTGS2 and melanoma: Further, it could be shown that improvement of ECOG status and cachexia control in melanoma patients may be mediated by pioglitazone/COX-2-related disruption of platelet derived aberrant serum protein and lipid crosstalk between lipolysis of fat tissue and muscle wasting associated oxidative stress, that are both mediating cachexia (138, 139).